Merit Medical Systems (NASDAQ:MMSI) Shares Break Below Fifty Day Moving Average – Should You Sell?

Merit Medical Systems, Inc. (NASDAQ:MMSI)’s stock price crossed below its 50 day moving average during trading on Friday. The stock has a 50 day moving average of $88.60 and traded as low as $84.00. Merit Medical Systems shares last traded at $86.24, with a volume of 1,804,091 shares changing hands.

Key Merit Medical Systems News

Here are the key news stories impacting Merit Medical Systems this week:

• Positive Sentiment: Strong Q3 earnings beat expectations. Merit reported third-quarter revenue of $416.2 million, up 8.4% year over year and ahead of the $410.6 million consensus estimate. Non-GAAP EPS was $1.12 versus expectations of $1.04, while GAAP EPS rose 51% to $0.70. Merit Medical Q3 2026 results
• Positive Sentiment: Profitability and cash generation improved. Organic constant-currency revenue increased 9%, GAAP operating margin expanded to 14.1% from 11.1%, and year-to-date operating cash flow reached $175.2 million, with $129.5 million in free cash flow.
• Positive Sentiment: Full-year guidance was raised. Management increased its 2026 earnings outlook following the strong quarter, supporting expectations for continued growth. Merit Medical raises 2026 guidance
• Positive Sentiment: Analysts raised targets. BTIG Research lifted its target from $105 to $110 and maintained a buy rating. Wells Fargo raised its target from $83 to $92, although it retained an equal-weight rating. Analysts raise Merit Medical price targets
• Positive Sentiment: Cardiac-therapy capabilities expanded. Merit acquired Solo Pace, adding temporary pacing technology designed for patients with aortic stenosis and strengthening its TAVR-related product portfolio. Merit Medical acquires Solo Pace
• Neutral Sentiment: Valuation remains a consideration. With the stock trading at roughly 36 times earnings and near its 52-week high, investors may be demanding continued execution, leaving limited room for disappointment.
• Negative Sentiment: Some caution remains among analysts. Wells Fargo’s equal-weight rating and the company’s narrowed sales outlook temper the bullish impact of the earnings beat and guidance increase.

Wall Street Analysts Forecast Growth

A number of equities analysts have recently weighed in on MMSI shares. BTIG Research lifted their price target on shares of Merit Medical Systems from $105.00 to $110.00 and gave the stock a “buy” rating in a research report on Friday. JPMorgan Chase & Co. boosted their price target on shares of Merit Medical Systems from $95.00 to $110.00 and gave the company an “overweight” rating in a report on Friday. Needham & Company LLC upped their price objective on shares of Merit Medical Systems from $101.00 to $106.00 and gave the company a “buy” rating in a research report on Friday. Robert W. Baird set a $98.00 price objective on Merit Medical Systems in a research note on Friday, July 31st. Finally, Piper Sandler raised their price objective on Merit Medical Systems from $96.00 to $106.00 and gave the stock an “overweight” rating in a research note on Friday, July 31st. Eight analysts have rated the stock with a Buy rating and five have assigned a Hold rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average target price of $105.55.

Merit Medical Systems Price Performance

The company has a debt-to-equity ratio of 0.44, a quick ratio of 2.79 and a current ratio of 4.20. The company has a 50-day moving average of $88.60 and a 200-day moving average of $77.14. The firm has a market capitalization of $5.15 billion, a price-to-earnings ratio of 32.42, a price-to-earnings-growth ratio of 2.33 and a beta of 0.51.

Merit Medical Systems (NASDAQ:MMSI) last posted its earnings results on Thursday, October 29th. The medical instruments supplier reported $1.12 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.04 by $0.08. The business had revenue of $416.24 million during the quarter, compared to analysts’ expectations of $410.56 million. Merit Medical Systems had a return on equity of 14.37% and a net margin of 9.94%. Merit Medical Systems’s revenue for the quarter was up 8.4% compared to the same quarter last year. During the same period in the prior year, the business earned $0.92 EPS. As a group, research analysts anticipate that Merit Medical Systems, Inc. will post 3.84 EPS for the current fiscal year.

Institutional Investors Weigh In On Merit Medical Systems

Large investors have recently made changes to their positions in the stock. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC grew its position in Merit Medical Systems by 11.7% in the second quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 173,854 shares of the medical instruments supplier’s stock valued at $12,055,000 after purchasing an additional 18,276 shares in the last quarter. Jupiter Topco LLC bought a new stake in Merit Medical Systems during the 2nd quarter worth about $1,908,000. Trillium Asset Management LLC bought a new stake in Merit Medical Systems during the 2nd quarter worth about $6,105,000. Irenic Capital Management LP acquired a new position in shares of Merit Medical Systems during the 2nd quarter worth about $37,623,000. Finally, Quantinno Capital Management LP boosted its stake in shares of Merit Medical Systems by 200.3% during the 1st quarter. Quantinno Capital Management LP now owns 17,612 shares of the medical instruments supplier’s stock worth $1,214,000 after buying an additional 11,747 shares during the last quarter. Institutional investors own 99.66% of the company’s stock.

About Merit Medical Systems

Merit Medical Systems, Inc is a medical device company that develops, manufactures and distributes disposable products used in interventional, diagnostic and therapeutic procedures. Its devices are designed for use by healthcare professionals in hospitals, outpatient facilities and other clinical settings.

The company’s product portfolio includes devices for vascular access, angiography, intervention, drainage, embolization, oncology and cardiac procedures. Merit also offers products used in peripheral intervention, spine procedures and other specialized areas of minimally invasive medicine, including kits, accessories and related procedural equipment.

Founded in 1987 and headquartered in South Jordan, Utah, Merit Medical serves healthcare providers through a global commercial and manufacturing network.